Digestive Fistulae — Efficacy and Safety of Lanreotide Versus Placebo for Treatment of Patients With Digestive Fistulae
Citation(s)
A Phase III Multicentre Randomised Double-blind Comparative Study of Efficacy and Safety of Lanreotide 30 mg Versus Placebo for Treatment of Patients With Digestive Fistulae